Beximco Pharmaceuticals Limited

BXP.L · LSE
Analyze with AI
12/31/2024
9/30/2024
6/30/2024
3/31/2024
Assets
Cash & Equivalents£1,655£859£854£1,160
Short-Term Investments£700£450£200£200
Receivables£4,626£6,770£6,454£3,759
Inventory£15,098£14,145£13,015£13,532
Other Curr. Assets£2,553£310£295£2,791
Total Curr. Assets£24,632£22,534£20,818£21,814
Property Plant & Equip (Net)£43,694£42,929£43,049£42,904
Goodwill£675£675£675£675
Intangibles£4,722£4,685£4,721£4,749
Long-Term Investments-£679-£429-£179-£179
Tax Assets£58£55£61£200
Other NC Assets£700£450£200£61
Total NC Assets£49,170£48,364£48,526£48,410
Other Assets£0£0£0£0
Total Assets£73,802£70,898£69,344£70,223
Liabilities
Payables£3,303£3,904£3,671£4,550
Short-Term Debt£4,169£2,093£3,136£5,824
Tax Payable£829£664£429£621
Deferred Revenue£0£0£0£0
Other Curr. Liab.£3,239£2,594£2,325£1,147
Total Curr. Liab.£11,539£9,255£9,562£12,142
LT Debt£2,025£0£1,758£1,604
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£2,564£2,570£2,575£0
Other NC Liab.£4,046£5,477£3,547£6,067
Total NC Liab.£8,634£8,048£7,879£7,671
Other Liabilities£0£0£0£0
Cap. Leases£383£0£464£482
Total Liabilities£20,173£17,303£17,441£19,813
Equity
Pref Stock£0£0£0£0
Common Stock£4,461£4,461£4,461£4,461
Retained Earnings£36,807£36,761£35,079£33,599
AOCI£1,449£1,450£1,450£1,451
Other Equity£6,959£6,959£6,959£6,959
Total Equity£49,676£49,631£47,950£46,471
Supplemental Information
Minority Interest£3,953£3,964£3,953£3,940
Total Liab. & Tot. Equity£73,802£70,898£69,344£70,223
Net Debt£4,538£1,234£4,040£6,268